Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DC7560 TAPI-1

TAPI-1 is a specific TACE(TNF-α-converting enzyme) inhibitor.

171235-71-5
DC7207 Tarafenacin(SVT-40776)

Tarafenacin(SVT-40776) is a highly selective M3 muscarinic receptor antagonist (Ki= 0.19 nM), ~200 fold selectivity over M2 receptor.

385367-47-5
DC9499 Tarafenacin (D-tartrate)

Tarafenacin(SVT-40776) is a highly selective M3 muscarinic receptor antagonist (Ki= 0.19 nM), ~200 fold selectivity over M2 receptor.

1159101-48-0
DC4158 Tranabant (MK-0364)

Taranabant is a highly selective cannabinoid-1 (CB1) receptor inverse agonist.

701977-09-5
DC20095 Target Protein-binding moiety 6 hydrochloride

Target Protein-binding moiety 6 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.

DC1102 Tariquidar (XR9576) Featured

Tariquidar (XR9576) is a potent and selective noncompetitive inhibitor of P-glycoprotein with Kd of 5.1 nM.

206873-63-4
DC21733 TAS05567

TAS05567 (TAS-5567) is a novel potent, selective, orally available Spleen tyrosine kinase (Syk) inhibitor with IC50 of 0.37 nM.

1429038-15-2
DC22243 TAS0728 Featured

TAS0728 (TAS-0728, TAS 0728) is a potent, selective, covalent, orally available inhibitor of HER2 kinase with IC50 of 36 nM in in vitro kinase assays.

2088323-16-2
DC7898 TAS-103(BMS247615)

TAS-103(BMS-247615) is a dual inhibitor of topoisomerase-I (topo-I) and topoisomerase-II (topoII).

174634-08-3
DC21734 TAS-114

TAS-114 is a first-in-class, potent, dual dUTPase/DPD inhibitor with Ki of 0.13/2.14 uM, respectively.

1198221-21-4
DC20274 Pamufetinib (TAS-115) Featured

Pamufetinib (TAS-115) is a potent VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.

1190836-34-0
DC21737 TAS-117 hydrochloride

TAS-117 is a potent, selective, allosteric inhibitor of Akt with IC50 of 4.8/1.6/44 for Akt1/2/3, respectively.

DC21255 Tasisulam sodium

Tasisulam (LY 573636) is a small molecule antitumor agent that induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death.

519055-63-1
DC7512 Tasosartan

Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertensionFor the detailed information of Tasosartan, the solubility of Tasosartan in water, the solubility of Tasosartan in DMSO, the solubility of Tasosartan in PBS buffer, the animal experiment (test) of Tasosartan, the cell expriment (test) of Tasosartan, the in vivo, in vitro and clinical trial test of Tasosartan, the EC50, IC50,and Affinity of Tasosartan, Please contact DC Chemicals..

145733-36-4
DC22416 TASP0376377

TASP0376377 is a potent, selective prostaglandin D2 receptor (CRTH2) antagonist with binding IC50 of 19 nM.

1233246-60-0
DC22528 Taspoglutide Featured

Taspoglutide is a glucagon-like peptide-1(GLP-1) agonist for treatment of type 2 diabetes.

275371-94-3
DC22522 Tat-NR2B9c Featured

Tat-NR2B9c (NA-1) is a neuroprotective agent.

500992-11-0
DC7619 Tazarotenic acid (AGN 190299) Featured

Tazarotenic Acid is an agent that acts as the principle active metabolite

118292-41-4
DC10411 TB500-2

TB500-2 is one of the TB500 metabolites. TB500 is a synthetic version of an active region of thymosin β4. TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decreas

DC7940 TBA-354

TBA-354 is a potent anti-tuberculosis compound; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates.

1257426-19-9
DC10300 Tbid

tBID is a selective inhibitor of homeodomain–interacting protein kinase 2 (HIPK2) with an IC50 of  0.33 µM.

1639895-85-4
DC20565 TBK1-IKKε inhibitor II

TBK1-IKKε inhibitor II is a potent, selective dual inhibitor of TBK1/IKKε with IC50 of 13 nM/59 nM, respectively.

1381930-17-1
Page 257 / Total 1557 FirstPrevNextLastGoto